Medipyxis
blog9 min read

Vascular Access Site Wounds: Assessment and Management

Clinical guide to vascular access site wound management covering dialysis access wounds, PICC site complications, port site care, and team coordination.

D

Damon Ebanks

Medipyxis

Vascular Access Site Wounds: Assessment and Management

Vascular Access Site Wounds: A Specialized Assessment Challenge

Vascular access site wounds present wound care clinicians with a unique intersection of wound management and device-dependent life-sustaining therapy. These wounds occur at sites where patients depend on functioning vascular access for hemodialysis, intravenous medications, parenteral nutrition, or chemotherapy. The clinical stakes are unusually high: mismanagement can result in access loss, bloodstream infection, or interruption of treatment that the patient cannot survive without.

An estimated 500,000 patients in the United States receive hemodialysis through vascular access sites, and millions more have PICCs, ports, or tunneled catheters for long-term intravenous therapy. Wound complications at these sites are common, and wound care clinicians are increasingly called upon to manage them. This guide covers the assessment and management of wounds at the three most common vascular access types: dialysis access (AV fistulas and grafts), PICC lines, and implanted ports.


Dialysis Access Wound Management

Dialysis access sites — arteriovenous (AV) fistulas and AV grafts — are the lifeline for hemodialysis patients. Wounds at these sites require a management approach that prioritizes access preservation alongside wound healing.

Common Dialysis Access Wound Types

  • Cannulation site wounds — repeated needle insertion at the same sites causes skin breakdown, scarring, and aneurysmal dilation; buttonhole cannulation technique creates a defined track that is particularly vulnerable to infection
  • Skin erosion over AV grafts — synthetic grafts (PTFE) are placed subcutaneously and can erode through thinned, irradiated, or steroid-affected skin, creating a wound with exposed graft material
  • Pseudoaneurysm — localized dilation at cannulation sites can thin the overlying skin to the point of threatened or actual rupture; this is a vascular emergency if the skin is paper-thin or actively bleeding
  • Steal syndrome wounds — steal syndrome occurs when the AV access diverts blood flow from the distal extremity, causing ischemic wounds on the hand or fingers; these wounds will not heal while the steal persists
  • Access site infection — localized infection at cannulation sites can range from superficial cellulitis to deep graft infection with sepsis risk

Assessment Priorities

When evaluating a dialysis access site wound:

  1. Assess access function first — is the access still being used for dialysis? Palpate for thrill (a vibration indicating flow) and auscultate for bruit (a swooshing sound). A functioning access must not be compromised by wound care interventions
  2. Determine wound etiology — is the wound from cannulation trauma, skin erosion, infection, or ischemia? The etiology drives management
  3. Evaluate for exposed graft material — if synthetic graft is visible in the wound base, this is an urgent finding that requires vascular surgery consultation; exposed graft material is at high risk for infection and may require graft revision
  4. Assess for signs of infection — erythema, warmth, purulence, and tenderness at dialysis access sites must be taken seriously; access site infections can seed the bloodstream during dialysis and cause endocarditis or septic emboli
  5. Check distal perfusion — assess the hand for color, temperature, capillary refill, and pulse quality; ischemic findings suggest steal syndrome

For comprehensive infection assessment methodology, see our guide on wound infection assessment.

Management Principles

  • Coordinate with the dialysis unit — the dialysis nursing staff and nephrologist must know about access site wounds; cannulation technique may need modification (moving cannulation sites, switching from buttonhole to rope-ladder technique) to allow wound healing
  • Avoid circumferential dressings — never wrap dressings circumferentially around the extremity containing the access; compression can occlude the access and cause thrombosis
  • Use non-adherent wound contact layers — traumatic dressing removal at access sites risks damaging the access or reopening cannulation wounds; non-adherent dressings minimize this risk
  • Urgent vascular referral for exposed graft, pseudoaneurysm with thinning skin, or steal syndrome — these are vascular surgical problems that wound care alone cannot resolve

PICC Site Complications

Peripherally inserted central catheters (PICCs) are placed in upper arm veins with the catheter tip positioned in the superior vena cava. PICC site wounds are common, particularly in patients with prolonged dwell times.

Common PICC Site Wound Types

  • Exit site infection — erythema, tenderness, and purulence at the catheter exit site; PICC-related bloodstream infections (CLABSI) are a serious complication that may require catheter removal
  • Contact dermatitis — allergic or irritant reaction to adhesive dressings (CHG-impregnated dressings, transparent films, or tape) causing periaccess skin breakdown
  • Mechanical irritation — catheter movement causes friction injury at the exit site, particularly in patients with upper extremity edema or poorly secured catheters
  • Skin tears — fragile skin (elderly patients, steroid-affected skin) tears during dressing changes, creating wounds adjacent to the PICC insertion site

Assessment and Management

  • Differentiate infection from dermatitis — both present with erythema around the PICC site, but infection typically includes tenderness, warmth, and purulent drainage, while contact dermatitis presents with an erythematous or vesicular rash that follows the outline of the adhesive dressing
  • Culture the exit site if infection is suspected — a positive exit site culture with matching blood cultures confirms catheter-related bloodstream infection and typically requires catheter removal
  • Address adhesive sensitivity — switch to a hypoallergenic securement device; consider skin barrier wipes before dressing application; in severe cases, use gauze dressings with a securement device instead of transparent films
  • Secure the catheter — stabilization devices (StatLock or similar) reduce pistoning motion that causes mechanical irritation; ensure the catheter hub is supported and not pulling on the exit site
  • Skin tear prevention — use silicone-based adhesive removers when changing dressings on fragile skin; remove dressings slowly in the direction of hair growth; consider bordered foam dressings as an alternative to transparent films

Implanted Port Site Management

Implanted ports (Port-a-Cath, Mediport, BardPort) are surgically placed subcutaneously, typically in the upper chest, with a catheter threaded into the superior vena cava. Port site wounds are less common than PICC complications but present unique challenges.

Common Port Site Wound Types

  • Port pocket infection — infection of the subcutaneous pocket containing the port body; presents as erythema, swelling, warmth, and tenderness over the port; may progress to port erosion through the skin
  • Skin erosion — the port body erodes through overlying skin, particularly in cachectic patients with minimal subcutaneous tissue; exposed port hardware is at extreme infection risk
  • Needle stick site wounds — Huber needle insertions create small wounds that usually heal quickly, but repeated access at the same site can cause skin breakdown
  • Postoperative wound complications — surgical site infection, dehiscence, or hematoma at the port implantation incision

Assessment and Management

  • Exposed port hardware is an emergency — any visible port component through a skin wound requires immediate consultation with the team that placed the port (interventional radiology, surgery, or oncology); the port will almost certainly need to be removed
  • Port pocket infection requires systemic treatment — unlike superficial wound infections, port pocket infections typically require both systemic antibiotics and port removal; local wound care alone is insufficient
  • Protect the port from wound care products — when managing wounds near the port site, ensure wound care products (silver dressings, iodine, honey) do not contact the port access area or compromise the sterile field for port access
  • Coordinate with infusion therapy — if the port is actively being accessed for chemotherapy, TPN, or other infusions, the infusion nursing team must be informed of any wound near the port site; access technique or site protection may need modification

Coordination with the Vascular Access Team

Vascular access site wounds require tighter interdisciplinary coordination than most wound types. The wound care clinician does not manage these wounds in isolation.

Essential Communication Points

When you identify a wound at a vascular access site, communicate the following to the relevant team:

  • Access type and location — specify AV fistula vs. graft, PICC vs. port, and exact anatomic location
  • Wound characteristics — size, depth, presence of exposed hardware or graft material, signs of infection
  • Access function status — is the access still functioning? Is the wound affecting access usability?
  • Recommended wound management plan — what you plan to do for the wound, including any interventions that might affect access use (dressing placement, debridement near the access, recommended activity restrictions)
  • Urgency assessment — clearly communicate when findings require urgent vascular surgery consultation (exposed graft, threatened pseudoaneurysm rupture, steal syndrome) versus findings that can be managed with routine follow-up

Documentation Standards

Document vascular access site wounds with additional specificity beyond standard wound documentation. For standard documentation framework guidance, see our guide on wound care documentation templates.

Access-specific documentation should include:

  • Access type, maturity, and functional status (thrill, bruit for AV access; patency for PICC/port)
  • Relationship of the wound to the access — is the wound at the access site, adjacent to it, or separate?
  • Impact on access usability — can the access still be used for its intended purpose?
  • Communication log — document all communication with the vascular access team, dialysis unit, infusion therapy, or procedural team regarding the wound

Key Takeaways

  • Vascular access site wounds require dual priorities — preserving the functioning access while managing the wound; never allow wound care interventions to compromise a working access that the patient depends on for life-sustaining therapy.
  • Exposed synthetic graft material or port hardware is an urgent finding that requires immediate vascular surgery or procedural team consultation; these wounds cannot be managed with local wound care alone.
  • Never apply circumferential dressings to extremities containing dialysis access — compression can occlude the access, cause thrombosis, and result in permanent access loss.
  • Differentiate infection from contact dermatitis at PICC sites — both cause periaccess erythema, but the management is opposite (antibiotics and possible catheter removal for infection versus hypoallergenic dressings for dermatitis).
  • Coordinate with the vascular access team, dialysis unit, or infusion therapy before making wound care changes that could affect access use, cannulation sites, or sterile access fields.

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.